Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


17.10.2022

3 Am J Cardiol
1 Am J Emerg Med
1 Ann Thorac Surg
1 BMJ
1 Circulation
1 Clin Cardiol
1 Eur Heart J
3 Int J Cardiol
1 J Am Coll Cardiol
12 J Cardiovasc Electrophysiol
4 J Cardiovasc Pharmacol
1 J Electrocardiol
16 J Interv Card Electrophysiol
1 J Thorac Cardiovasc Surg
1 Lancet
3 Pacing Clin Electrophysiol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. COVINGTON MK, Young PM, Bois MC, Maleszewski JJ, et al
    Clinical Impact of Cardiac Fibromas.
    Am J Cardiol. 2022;182:95-103.
    PubMed         Abstract available

  2. CHO MS, Kang DH, Choi KJ
    Reply to the Comment on "Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation".
    Am J Cardiol. 2022 Oct 10. pii: S0002-9149(22)00995.
    PubMed        

  3. S H ABRAHIM M, Sofola-James O, Bani Hani Z
    Comparison of Dabigatran Versus Warfarin Treatment for the Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation.
    Am J Cardiol. 2022 Oct 7. pii: S0002-9149(22)00956.
    PubMed        


    Am J Emerg Med

  4. MOHAMED AK, Nayaz MS, Nawaz A, Kapadia C, et al
    Keep shocking: A case report of double sequential defibrillation for refractory ventricular fibrillation.
    Am J Emerg Med. 2022 Sep 30. pii: S0735-6757(22)00608.
    PubMed         Abstract available


    Ann Thorac Surg

  5. CHENG YT, Huang YT, Tu HT, Chan YH, et al
    Long-term Outcomes of Concomitant Surgical Ablation for Atrial Fibrillation.
    Ann Thorac Surg. 2022 Oct 7. pii: S0003-4975(22)01297.
    PubMed         Abstract available


    BMJ

  6. MAHASE E
    Atrial fibrillation: Most UK media "promote screening" despite lack of evidence, study finds.
    BMJ. 2022;379:o2449.
    PubMed        


    Circulation

  7. VISKIN S, Chorin E, Schwartz AL, Kukla P, et al
    Arrhythmogenic Effects of Cardiac Memory.
    Circulation. 2022;146:1170-1181.
    PubMed         Abstract available


    Clin Cardiol

  8. SHEN Z, Chen D, Cheng H, Tan F, et al
    N-terminal pro-B-type natriuretic peptide and D-dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation.
    Clin Cardiol. 2022 Oct 8. doi: 10.1002/clc.23933.
    PubMed         Abstract available


    Eur Heart J

  9. SHIN J, Han K, Jung JH, Park HJ, et al
    Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
    PubMed         Abstract available


    Int J Cardiol

  10. XU W, Lv M, Wu T, Huang N, et al
    Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01460.
    PubMed         Abstract available

  11. FISCHLEIN T, Caporali E, Folliguet T, Kappert U, et al
    Randomized controlled trial between conventional versus sutureless bioprostheses for aortic valve replacement: Impact of mini and full sternotomy access at 1-year follow-up.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01179.
    PubMed         Abstract available

  12. IWAKAWA H, Terata K, Kato R, Kaimori R, et al
    Utility of P-wave abnormalities for distinguishing embolic stroke from non-embolic stroke.
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01247.
    PubMed         Abstract available


    J Am Coll Cardiol

  13. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    PubMed         Abstract available


    J Cardiovasc Electrophysiol

  14. HANGIEL U, Kusnierz J, Bardyszewski A, Dzwonkowska D, et al
    Atrial electrogram amplitude variability during atrial fibrillation ablation.
    J Cardiovasc Electrophysiol. 2022 Oct 11. doi: 10.1111/jce.15702.
    PubMed         Abstract available

  15. HONARBAKHSH S, Schilling RJ, Keating E, Finlay M, et al
    Coronary sinus electrogram characteristics predict termination of AF with ablation and long-term clinical outcome.
    J Cardiovasc Electrophysiol. 2022;33:2139-2151.
    PubMed         Abstract available

  16. YANG H, Sun H, Li Y, Si D, et al
    Rare left-sided accessory pathway successfully ablated with atrial insertion site at the left-side fossa ovalis.
    J Cardiovasc Electrophysiol. 2022;33:2224-2227.
    PubMed         Abstract available

  17. CHOI Y, Kim SH, Kim H, Park JW, et al
    The advantage of the mini-electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia.
    J Cardiovasc Electrophysiol. 2022;33:2164-2171.
    PubMed         Abstract available

  18. IWASAWA J, Koruth JS
    The mini electrode-equipped catheter: Utility for paroxysmal supraventricular tachycardia ablation.
    J Cardiovasc Electrophysiol. 2022;33:2172-2173.
    PubMed        

  19. ENE E, Halbfass P, Nentwich K, Sonne K, et al
    Optimal cut-off value for endocardial bipolar voltage mapping using a multipoint mapping catheter to characterize the scar regions described in cardio-CT with myocardial thinning.
    J Cardiovasc Electrophysiol. 2022;33:2174-2180.
    PubMed         Abstract available

  20. FINK T, Sciacca V, Sommer P
    CT-imaging versus high-density mapping in ischemic cardiomyopathy VT ablation: In whom do we trust?
    J Cardiovasc Electrophysiol. 2022;33:2181-2182.
    PubMed        

  21. MEROVCI I, Gulcu O, Tuncez A, Kara M, et al
    Unusual response to His-synchronous ventricular stimulation during a supraventricular tachycardia: Atrial advancement with or without resetting?
    J Cardiovasc Electrophysiol. 2022;33:2217-2219.
    PubMed        

  22. MURTHI M, Vardar U, Sana MK, Shaka H, et al
    Causes and predictors of immediate and short-term readmissions following percutaneous left atrial appendage closure procedure.
    J Cardiovasc Electrophysiol. 2022;33:2213-2216.
    PubMed         Abstract available

  23. SHIMENO K, Tamura S, Hayashi Y, Abe Y, et al
    Reply to "Is left ventricular septal pacing enough clinically, or must left bundle branch be captured absolutely?"
    J Cardiovasc Electrophysiol. 2022;33:2234.
    PubMed        

  24. NAKASHIMA T, Nagase M, Shibahara T, Ono D, et al
    Ventricular overdrive pacing during supraventricular tachycardia with alternating cycle length: What is the diagnosis?
    J Cardiovasc Electrophysiol. 2022;33:2220-2223.
    PubMed        

  25. ZHU K, Chang D, Li L, Liu J, et al
    Is left ventricular septal pacing enough clinically, or must left bundle branch be captured absolutely?
    J Cardiovasc Electrophysiol. 2022;33:2233.
    PubMed        


    J Cardiovasc Pharmacol

  26. BERNARDI M, Spadafora L, Biondi-Zoccai G
    Should we consider recombinant human brain natriuretic peptide to prevent post-operative atrial fibrillation?
    J Cardiovasc Pharmacol. 2022 Oct 10. pii: 00005344-990000000-00120.
    PubMed        

  27. ESSA H, Dobson R, Lip GYH
    Chemotherapy-Induced Arrhythmias.
    J Cardiovasc Pharmacol. 2022;80:531-539.
    PubMed         Abstract available

  28. PILOTE S, Simard C, Drolet B
    Remdesivir (VEKLURY) for Treating COVID-19: Guinea Pig Ex Vivo and In Vivo Cardiac Electrophysiological Effects.
    J Cardiovasc Pharmacol. 2022;80:616-622.
    PubMed         Abstract available

  29. HOSSEINI SH, Talasaz AH, Alidoosti M, Tajdini M, et al
    Pre-Procedural Colchicine in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: a Randomized Controlled Trial (PodCAST-PCI).
    J Cardiovasc Pharmacol. 2022 Jun 22. pii: 00005344-990000000-00067.
    PubMed         Abstract available


    J Electrocardiol

  30. PLONEDA-VALENCIA RG, Ortiz-Solis WA, Ruiz-Gonzalez G, Santiago-Garcia AK, et al
    Supraventricular tachyarrhythmia and sinus node dysfunction as a first manifestation of short QT syndrome in a pediatric patient. Case Report.
    J Electrocardiol. 2022;74:146-153.
    PubMed         Abstract available


    J Interv Card Electrophysiol

  31. ISAKSEN JL, Manninger M, Linz D
    The right modality for the right pulmonary vein shape in ablation for atrial fibrillation.
    J Interv Card Electrophysiol. 2022 Oct 10. pii: 10.1007/s10840-022-01390.
    PubMed        

  32. GOMEZ SE, Fazal M, Nunes JC, Shah S, et al
    Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.
    J Interv Card Electrophysiol. 2022 Oct 13. pii: 10.1007/s10840-022-01383.
    PubMed         Abstract available

  33. FALASCONI G, Penela D, Soto-Iglesias D, Francia P, et al
    Preventive substrate ablation in chronic post-myocardial infarction patients with high-risk scar characteristics for ventricular arrhythmias: rationale and design of PREVENT-VT study.
    J Interv Card Electrophysiol. 2022 Oct 13. pii: 10.1007/s10840-022-01392.
    PubMed         Abstract available

  34. VERGARA P, Pannone L, Calvo F, Falasconi G, et al
    Physical activity volume in patients with arrhythmogenic cardiomyopathy is associated with recurrence after ventricular tachycardia ablation.
    J Interv Card Electrophysiol. 2022;65:15-24.
    PubMed         Abstract available

  35. HIJIOKA N, Kaneshiro T, Nehashi T, Amami K, et al
    Influence of power setting on superior vena cava potential during right pulmonary vein isolation.
    J Interv Card Electrophysiol. 2022;65:25-31.
    PubMed         Abstract available

  36. TAMURA S, Shimeno K, Nakatsuji K, Hayashi Y, et al
    Differences in the durability of left atrial posterior wall isolation based on the isolation process.
    J Interv Card Electrophysiol. 2022;65:45-51.
    PubMed         Abstract available

  37. VOGL BJ, Shaer AE, Van Zyl M, Killu AM, et al
    Effect of catheter ablation on the hemodynamics of the left atrium : Hemodynamics of ablation.
    J Interv Card Electrophysiol. 2022;65:83-96.
    PubMed         Abstract available

  38. SCHILLACI V, Strisciuglio T, Stabile G, Salito A, et al
    Cavotricuspid isthmus ablation by means of very high power, short-duration, temperature-controlled lesions.
    J Interv Card Electrophysiol. 2022;65:97-102.
    PubMed         Abstract available

  39. NICOSIA A, Iacopino S, Nigro G, Zucchelli G, et al
    Performance of transcatheter pacing system use in relation to patients' age.
    J Interv Card Electrophysiol. 2022;65:103-110.
    PubMed         Abstract available

  40. SOUSA PA, Puga L, Barra S, Campos D, et al
    High-sensitivity Troponin I and Ablation Effectiveness Quotient after Ablation Index-guided pulmonary vein isolation-markers of arrhythmia recurrence?
    J Interv Card Electrophysiol. 2022;65:115-121.
    PubMed         Abstract available

  41. SEKIHARA T, Miyazaki S, Aoyama D, Nagao M, et al
    Evaluation of cryoballoon pulmonary vein isolation lesions during the acute and chronic phases using a high-resolution mapping system.
    J Interv Card Electrophysiol. 2022;65:123-131.
    PubMed         Abstract available

  42. HSU JC, Darden D, Glover BM, Colley BJ 3rd, et al
    Performance and acute procedural outcomes of the EnSite Precision cardiac mapping system for electrophysiology mapping and ablation procedures: results from the EnSite Precision observational study.
    J Interv Card Electrophysiol. 2022;65:141-151.
    PubMed         Abstract available

  43. GASIMOVA NZ, Nechepurenko AA, Kropotkin EB, Ivanitsky EA, et al
    Performance of the ablation index during pulmonary vein isolation: periprocedural data from a multicenter registry.
    J Interv Card Electrophysiol. 2022;65:167-177.
    PubMed         Abstract available

  44. JEMTREN A, Bergfeldt L, Insulander P, Rubulis A, et al
    Accessory pathway properties are similar in symptomatic and asymptomatic preexcitation.
    J Interv Card Electrophysiol. 2022;65:193-199.
    PubMed         Abstract available

  45. TAPIAS C, Enriquez A, Santangeli P, Rodriguez D, et al
    Intracardiac echocardiography as an adjunctive tool for accessory pathway ablation in Ebstein anomaly.
    J Interv Card Electrophysiol. 2022;65:201-207.
    PubMed         Abstract available

  46. O'NEILL L, Sim I, O'Hare D, Whitaker J, et al
    Provocation and localization of atrial ectopy in patients with atrial septal defects.
    J Interv Card Electrophysiol. 2022;65:227-237.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  47. MCCARTHY PM, Cox JL
    Author Reply to Commentary: Increasing atrial fibrillation ablation: Insanity is doing the same thing over and over again, but expecting different results.
    J Thorac Cardiovasc Surg. 2022 Sep 20. pii: S0022-5223(22)01011.
    PubMed        


    Lancet

  48. FABRITZ L, Obergassel J
    Artificial intelligence for early atrial fibrillation detection.
    Lancet. 2022;400:1173-1175.
    PubMed        


    Pacing Clin Electrophysiol

  49. VETTA G, Parlavecchio A, Magnocavallo M, Valente D, et al
    Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: a metanalysis.
    Pacing Clin Electrophysiol. 2022 Oct 10. doi: 10.1111/pace.14603.
    PubMed         Abstract available

  50. CUI C, Li Z, Ju W, Yang G, et al
    The characteristics of pre-excitation syndrome concomitant with atrial tachyarrhythmia and the effect of radiofrequency ablation.
    Pacing Clin Electrophysiol. 2022 Oct 9. doi: 10.1111/pace.14598.
    PubMed         Abstract available

  51. WISEMAN K, Gor D, Udongwo N, Alshami A, et al
    Ventricular Arrhythmias in Kearns Sayre Syndrome: A Cohort Study Using the National Inpatient Sample Database 2016-2019.
    Pacing Clin Electrophysiol. 2022 Oct 8. doi: 10.1111/pace.14607.
    PubMed         Abstract available


    PLoS One

  52. BEIER L, Lu S, Franca LR, Marler S, et al
    Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
    PLoS One. 2022;17:e0274237.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: